PETRUCCI, GIOVANNA
 Distribuzione geografica
Continente #
AS - Asia 451
NA - Nord America 408
EU - Europa 109
SA - Sud America 64
AF - Africa 10
Totale 1.042
Nazione #
US - Stati Uniti d'America 380
CN - Cina 129
SG - Singapore 110
BD - Bangladesh 79
HK - Hong Kong 72
IT - Italia 46
BR - Brasile 42
EE - Estonia 40
MX - Messico 14
VN - Vietnam 14
AR - Argentina 6
CA - Canada 6
IN - India 6
PK - Pakistan 6
SA - Arabia Saudita 6
PH - Filippine 5
TR - Turchia 5
ES - Italia 4
FR - Francia 4
ID - Indonesia 4
VE - Venezuela 4
CR - Costa Rica 3
DE - Germania 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
GB - Regno Unito 2
GT - Guatemala 2
MA - Marocco 2
RU - Federazione Russa 2
UA - Ucraina 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
IQ - Iraq 1
JP - Giappone 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NL - Olanda 1
NO - Norvegia 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 1.042
Città #
San Jose 244
Hong Kong 71
Singapore 63
Ashburn 62
Beijing 50
Tallinn 40
Rome 10
New York 9
Santa Clara 9
Mexico City 8
São Paulo 8
Hanoi 5
Dallas 4
Ho Chi Minh City 4
Milan 4
Istanbul 3
Jeddah 3
Modena 3
San José 3
Buenos Aires 2
Cagliari 2
Dresden 2
Guatemala City 2
Houston 2
Kuala Lumpur 2
Lahore 2
Los Angeles 2
Montevideo 2
Prato 2
Rabat 2
Rio de Janeiro 2
Riyadh 2
Salvador 2
Abuja 1
Addis Ababa 1
Aire-sur-la-Lys 1
Al Ain City 1
Amiens 1
Ancona 1
Arequipa 1
Baguio City 1
Bakersfield 1
Bandera 1
Bandung 1
Barra Bonita 1
Beamsville 1
Belém 1
Benito Juarez 1
Bergamo 1
Bexley 1
Bracey 1
Brescia 1
Bắc Ninh 1
Calamba 1
Cameri 1
Campeche 1
Campo de Carabobo 1
Cape Town 1
Capri city 1
Caracas 1
Cardiff 1
Carmo do Cajuru 1
Carneiros 1
Castelló de la Plana 1
Catania 1
Celaya 1
Charles Town 1
Charlotte 1
Chernivtsi 1
Chisinau 1
Chía 1
Conselheiro Lafaiete 1
Coro 1
Corrientes 1
Council Bluffs 1
Craiova 1
Cumberland 1
Curicó 1
Da Nang 1
Dammam 1
Denia 1
Detroit 1
Dhaka 1
Du Quoin 1
Duque de Caxias 1
Durham 1
El Cajon 1
El Jagüel 1
Elgin 1
Ellettsville 1
Estância 1
Formia 1
Fortaleza 1
Frankfurt am Main 1
Fremont 1
Germantown 1
Girau do Ponciano 1
Greensboro 1
Guayaquil 1
Gunpo 1
Totale 698
Nome #
Abnormal Megakaryopoiesis and Platelet Function in Cyclooxygenase-2-Deficient Mice 65
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 64
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 54
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 38
Effect of Low-dose and Standard-dose Aspirin on PGE 2 Biosynthesis Among Individuals with Colorectal Adenomas: A Randomized Clinical Trial 33
Tumorigenic Potential of Olfactory Bulb-Derived Human Adult Neural Stem Cells Associates with Activation of TERT and NOTCH1 31
Stability of the thromboxane B2 biomarker of aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 29
Prolonged fasting promotes systemic inflammation and platelet activation in humans: a medically supervised, water-only fasting and refeeding study 23
Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts 23
Very-Low-Dose Twice-Daily Aspirin Maintains Platelet Inhibition and Improves Hemostasis during Dual-Antiplatelet Therapy for Acute Coronary Syndrome 22
Influence of local environment on the differentiation of neural stem cells engrafted onto the injured spinal cord 22
Telomerase inhibition impairs tumor growth in glioblastoma xenografts 22
A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 21
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 21
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 20
Long-term pharmacodynamic and clinical effects of twice-daily low-dose aspirin in patients with essential thrombocythemia: results from the ARES randomized phase-2 trial 19
Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21Waf1 protein up-regulation and Rb1 pathway modulation 19
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 19
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 19
Establishing tumor cell lines from aggressive telomerase-positive chordomas of the skull base. Technical note 18
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 18
Mesenchymal differentiation of glioblastoma stem cells 18
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 16
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 16
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 15
Thromboxane biosynthesis and risk of future events in diabetes mellitus: A sub-study of the ASCEND trial 15
. Effect of low-dose rivaroxaban with low-dose aspirin vs. low-dose aspirin on platelet and oxidative biomarkers: a randomized study in diabetes patients with stable peripheral or coronary artery disease 13
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 13
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 13
Distinct expression of cyclooxygenase-1 and -2 in the human thymus 13
Impact of COX-2 deletion on platelet and megakaryocyte phenotypes 13
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 12
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 12
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 12
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 12
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 11
Aspirin, stroke and drug-drug interactions 11
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 11
Poor responsiveness to low-dose aspirin contributes to persistent in vivo platelet activation in polycythemia vera 11
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 11
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 10
Mesenchymal differentiation of glioblastoma stem cells 10
Deletion of p66Shc gene restores endothelial function in a mouse model of obesity and insulin resistance 10
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 10
Preoperative psychological characteristics affecting mid-term outcome after bariatric surgery: a follow-up study 10
Pathophysiology of Thrombosis in Peripheral Artery Disease 10
Variability in the recovery rate of platelet cyclooxygenase activity during chronic therapy with low-dose aspirin in type 2 diabetes 10
In Vivo Platelet Activation In Impaired Glucose Tolerance And During Progression Of Type 2 Diabetes: A Cross-sectional And Longitudinal Study 10
Kinetics of 24-hour recovery of platelet TXA2 production: a methodological approach to describe and understand variability in low-dose aspirin response 9
prostaglandin E2 and EP3 activation potentiate human platelet responsiveness 9
Platelet Thromboxane Inhibition by Low-Dose Aspirin in Polycythemia Vera: Ex Vivo and In Vivo Measurements and In Silico Simulation. 9
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia 9
Effect of cyclooxygenase-2 (COX-2) delection on megakaryopoiesis and peripheral platelet phenotype 9
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 9
Tumorigenic potential of olfactory bulb derived human adult neural stem cells associates whit activation of TERT and NOTCH1. 9
In Vivo Platelet Activation And Aspirin Responsiveness In Type 1 Diabetes Mellitus 8
the Contribution of COX-1 and COX-2 to platelet activation in Essential Thrombocythemia: a clinical paradigm of aspirin-resistant thromboxane biosynthesis 8
Farmaci Antipiastrinici 8
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 8
Variable antiplatelet response to thyenopiridines: should we use lab tests? 8
Insulin Resistant Mice Lacking p66Shc Gene are Protected Against Endothelial Dysfunction 8
Platelet and megakaryocyte phenotypes of COX-2 deletion 8
VON WILLEBRAND FACTOR CHANGES IN ESSENTIAL THROMBOCYTHEMIA. ITS ROLE IN THROMBO-HAEMORRHAGIC COMPLICATIONS. 8
The lifespan determinant p66sch drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 7
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation 7
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 7
Personalized medicine, pharmacogenetics, and clopidogrel: unraveling variability of response 7
Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial 7
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samples 7
Von Willebrand factor levels in polycythemia vera are not reduced and can be predicted by erythrocyte counts 6
Totale 1.103
Categoria #
all - tutte 4.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202581 0 0 0 40 0 0 1 9 0 0 17 14
2025/20261.022 8 1 18 33 56 54 98 97 356 101 139 61
Totale 1.103